Carnegie Investment Counsel
TDOC icon

Carnegie Investment Counsel’s Teladoc Health TDOC Stock Holding History

Carnegie Investment Counsel’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,081
Closed -$264K – 514
2021
Q3 		$264K Sell
2,081
-25
-1% -$3.64K 0.01% 413
2021
Q2 		$350K Sell
2,106
-414
-16% -$67.1K 0.01% 370
2021
Q1 		$458K Buy
2,520
+551
+28% +$128K 0.02% 328
2020
Q4 		$394K Sell
1,969
-24,365
-93% -$4.95M 0.02% 326
2020
Q3 		$5.77M Sell
26,334
-4,941
-16% -$1.05M 0.3% 100
2020
Q2 		$5.97M Sell
31,275
-2,290
-7% -$401K 0.34% 85
2020
Q1 		$5.2M Sell
33,565
-12,575
-27% -$1.46M 0.36% 82
2019
Q4 		$3.86M Buy
46,140
+9,620
+26% +$732K 0.22% 119
2019
Q3 		$2.47M Buy
36,520
+22,140
+154% +$1.46M 0.16% 142
2019
Q2 		$955K Sell
14,380
-18,900
-57% -$1.1M 0.06% 222
2019
Q1 		$1.85M Buy
+33,280
New +$2.03M 0.13% 158

Other funds holding TDOC

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Carnegie Investment Counsel's TDOC Position: Q4 2021 in Review

Carnegie Investment Counsel sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 2,081 shares — an estimated $264K sold.

Carnegie Investment Counsel first reported a position in TDOC in Q1 2019 and held it in 11 quarters. The position peaked at $5.97M in Q2 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Carnegie Investment Counsel reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Carnegie Investment Counsel sold 2,081 Teladoc Health shares in Q4 2021, an estimated $264K.
  • Carnegie Investment Counsel first reported a position in Teladoc Health in Q1 2019 and held it in 11 quarters.
  • Carnegie Investment Counsel's Teladoc Health position peaked at $5.97M in Q2 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Carnegie Investment Counsel's 13F filing for Q4 2021, filed 21 Jan 2022.